Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07513194) titled 'GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)' on April 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Baylor College of Medicine
Condition:
Atypical Teratoid Rhabdoid Tumor
Central Nervous System Rhabdoid Tumor
Intervention:
Biological: 21.15.GPC3-CAR T Cells...
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 1, 2026
Target Sample Size: 21
Countries of Recruitment:
United States
To know m...